Back to SYRE

Paradigm Biocapital Advisors LP → SYRE

Paradigm Biocapital Advisors LP SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$396.8M
Q3 2026
Peak value
$396.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$48.1M
Q1 2026$98.7M
Q2 2026$341M
Q3 2026$396.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$396.8M4.46M——
Q2 2026$341M3.84M——
Q1 2026$98.7M1.96M——
Q4 2025$48.1M1.47M——

Other funds holding SYRE

Other Paradigm Biocapital Advisors LP positions

RVMDW

REVOLUTION MEDICINES INC

$1.3B
RVMDW

REVOLUTION MEDICINES INC

$1.2B
RVMDW

REVOLUTION MEDICINES INC

$647.3M
RVMDW

REVOLUTION MEDICINES INC

$529.2M
GNMSF

GENMAB A/S

$504.3M
EWTX

EDGEWISE THERAPEUTICS INC

$437.6M
EWTX

EDGEWISE THERAPEUTICS INC

$415.1M
GNMSF

GENMAB A/S

$360.8M